Susquehanna International Group, LLP Tff Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$0.43 - $0.77 $2,580 - $4,620	-6,000 Reduced 33.33%	12,000 $5,000
Q1 2023 May 16, 2023	BUY	$0.62 - $1.1 $3,720 - $6,600	6,000 Added 50.0%	18,000 $12,000
Q4 2022 Feb 14, 2023	BUY	$0.84 - $100.75 $10,080 - $1.21 Million	12,000 New	12,000 $12,000
Q2 2022 Aug 15, 2022	BUY	$3.99 - $7.22 $24,738 - $44,764	6,200 Added 10.49%	65,300 $369,000
Q1 2022 May 16, 2022	BUY	$5.28 - $9.17 $192,720 - $334,705	36,500 Added 161.5%	59,100 $373,000
Q4 2021 Feb 14, 2022	SELL	$6.86 - $9.65 $48,020 - $67,550	-7,000 Reduced 23.65%	22,600 $200,000
Q3 2021 Nov 15, 2021	BUY	$7.21 - $10.49 $105,266 - $153,154	14,600 Added 97.33%	29,600 $229,000
Q2 2021 Aug 11, 2021	SELL	$8.48 - $13.61 $289,168 - $464,101	-34,100 Reduced 69.45%	15,000 $144,000
Q1 2021 May 17, 2021	SELL	$12.96 - $19.75 $292,896 - $446,350	-22,600 Reduced 31.52%	49,100 $666,000
Q3 2020 Nov 16, 2020	BUY	$5.86 - $18.47 $420,162 - $1.32 Million	71,700 New	71,700 $1.32 Million

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $1.53M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.